Artificial Intelligence
In 2025, AI is transforming pharma marketing by enabling hyper-targeted campaigns and personalized patient engagement, leading to more effective outreach and higher conversion rates. To prepare, companies should invest in AI-driven analytics, upskill their workforce, and integrate AI tools into their marketing strategies to stay competitive.
The time is now to prepare your company for AI implementation. Doing so starts with the C-suite.
The early adoption of artificial intelligence/machine learning has centered around drug discovery, but the technologies are being applied to other fields, including pharma marketing.
In this episode of the In Vivo podcast, visionary University of Toronto researcher Alan Aspuru-Guzik talks about the value of generative AI, automation and quantum computing in drug discovery.
There is “a lot of flexibility” in the European Medicines Agency’s reflection paper on the use of artificial intelligence during drug development, which is principles-driven rather than setting rigid recommendations, says the agency’s Florian Lasch.